Nicotine activates YAP1 through nAChRs mediated signaling in Esophageal Squamous Cell Cancer (ESCC)

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zhao, Yue ^a   Zhou, Wei ^a   Xue, Liyan ^a   Zhang, Weimin ^a   Zhan, Qimin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CHRNA3 PROTEIN; ENZASTAURIN; NICOTINE; NICOTINIC RECEPTOR; PROTEIN 14 3 3; PROTEIN KINASE C; PROTEIN P63; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; YAP1 PROTEIN; NICOTINIC RECEPTOR SUBUNIT ALPHA3; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BRONCHUS CANCER; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; ENZYME ACTIVATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMOKING; UPREGULATION; ACTIVE TRANSPORT; CELL MOTION; DEFICIENCY; DRUG EFFECTS; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; NICOTINE; PHOSPHOPROTEINS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION;

EID: 84898016352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090836     Document Type: Article

References (41)

1. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, et al. (2001) Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 153: 114-122. (Pubitemid 32063186)
2. Wu AH, Wan P, Bernstein L (2001) A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12: 721-732. (Pubitemid 32807718)
3. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349: 2241-2252. (Pubitemid 37485141)
4. Schuller HM (2009) Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9: 195-205.
5. Bezakova G, Ruegg MA (2003) New insights into the roles of agrin. Nat Rev Mol Cell Biol 4: 295-308. (Pubitemid 36383956)
6. Ramarao MK, Cohen JB (1998) Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc Natl Acad Sci U S A 95: 4007-4012. (Pubitemid 28173244)
7. Chernyavsky AI, Arredondo J, Vetter DE, Grando SA (2007) Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. Exp Cell Res 313: 3542-3555. (Pubitemid 47404552)
8. Zhao B, Li L, Lei Q, Guan KL (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24: 862-874.
9. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267. (Pubitemid 43929093)
10. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405-12410. (Pubitemid 44267272)
11. Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, et al. (2011) YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32: 389-398.
12. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, et al. (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115: 4576-4585.
13. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, et al. (2006) Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A 103: 6332-6337.
14. Takeuchi H, Kubota S, Murakashi E, Zhou Y, Endo K, et al. (2010) Nicotine-induced CCN2: from smoking to periodontal fibrosis. J Dent Res 89: 34-39.
15. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, et al. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791.
16. Kabbani N, Woll MP, Levenson R, Lindstrom JM, Changeux JP (2007) Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics. Proc Natl Acad Sci U S A 104: 20570-20575.
17. Yeo MK, Kim SH, Kim JM, Huang SM, Kim MR, et al. (2012) Correlation of expression of phosphorylated and non-phosphorylated Yes-associated protein with clinicopathological parameters in esophageal squamous cell carcinoma in a Korean population. Anticancer Res 32: 3835-3840.
18. Al-Wadei MH, Al-Wadei HA, Schuller HM (2012) Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors alpha3, alpha5, and alpha7. Mol Cancer Res 10: 239-249.
19. Yamada K, Yaguchi T, Kanno T, Mukasa T, Nishizaki T (2010) Auto-positive feedback regulation for nicotinic acetylcholine receptors by protein kinase C activation. Cell Physiol Biochem 26: 247-252.
20. Brown EN, Galligan JJ (2003) Muscarinic receptors couple to modulation of nicotinic ACh receptor desensitization in myenteric neurons. Am J Physiol Gastrointest Liver Physiol 285: G37-44. (Pubitemid 36736386)
21. Tomlinson V, Gudmundsdottir K, Luong P, Leung KY, Knebel A, et al. (2010) JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis 1: e29.
22. Krais AM, Hautefeuille AH, Cros MP, Krutovskikh V, Tournier JM, et al. (2011) CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression. Carcinogenesis 32: 1388-1395.
23. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011) Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795.
24. Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, et al. (2012) beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151: 1457-1473.
25. Al-Wadei MH, Al-Wadei HA, Schuller HM (2012) Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters. Carcinogenesis 33: 1745-1753.
26. Al-Wadei HA, Al-Wadei MH, Schuller HM (2012) Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. PLoS One 7: e29915.
27. Hirata N, Sekino Y, Kanda Y (2010) Nicotine increases cancer stem cell population in MCF-7 cells. Biochem Biophys Res Commun 403: 138-143.
28. An Y, Kiang A, Lopez JP, Kuo SZ, Yu MA, et al. (2012) Cigarette smoke promotes drug resistance and expansion of cancer stem cell-like side population. PLoS One 7: e47919.
29. Yu CC, Chang YC (2013) Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL. Toxicol Appl Pharmacol 266: 459-469.
30. Yu MA, Kiang A, Wang-Rodriguez J, Rahimy E, Haas M, et al. (2012) Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma. PLoS One 7: e51967.
31. Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, et al. (2013) Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma. J Invest Dermatol.
32. Chen CL, Tsukamoto H, Liu JC, Kashiwabara C, Feldman D, et al. (2013) Reciprocal regulation by TLR4 and TGF-beta in tumor-initiating stem-like cells. J Clin Invest 123: 2832-2849.
33. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, et al. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772.
34. Clapham DE (2007) Calcium signaling. Cell 131: 1047-1058. (Pubitemid 350258556)
35. Greka A, Mundel P (2012) Calcium regulates podocyte actin dynamics. Semin Nephrol 32: 319-326.
36. He JQ, Pi Y, Walker JW, Kamp TJ (2000) Endothelin-1 and photoreleased diacylglycerol increase L-type Ca2+ current by activation of protein kinase C in rat ventricular myocytes. J Physiol 524 Pt 3: 807-820. (Pubitemid 30303627)
37. Rosenberg MM, Yang F, Giovanni M, Mohn JL, Temburni MK, et al. (2008) Adenomatous polyposis coli plays a key role, in vivo, in coordinating assembly of the neuronal nicotinic postsynaptic complex. Mol Cell Neurosci 38: 138-152.
38. Nakamura T, Hayashi T, Mimori-Kiyosue Y, Sakaue F, Matsuura K, et al. (2010) The PX-RICS-14-3-3zeta/theta complex couples N-cadherin-beta-catenin with dynein-dynactin to mediate its export from the endoplasmic reticulum. J Biol Chem 285: 16145-16154.
39. Zhang B, Luo S, Dong XP, Zhang X, Liu C, et al. (2007) Beta-catenin regulates acetylcholine receptor clustering in muscle cells through interaction with rapsyn. J Neurosci 27: 3968-3973. (Pubitemid 46597140)
40. Onoda N, Nehmi A, Weiner D, Mujumdar S, Christen R, et al. (2001) Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 23: 860-870. (Pubitemid 32862290)
41. Densham RM, O'Neill E, Munro J, Konig I, Anderson K, et al. (2009) MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability. Mol Cell Biol 29: 6380-6390.